Company: IMRX
Filing Date: 2025-08-13
Form Type: S-3
Source: 0001104659-25-077655
Chunk: 59

Company: Immuneering Corp
Filing Date: 2025-08-13
Form: S-3
Chunk 59
---
 and any appeal therefrom, if the Indemnitee acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, our best interests, except that no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable to us, unless a court determines that, despite such adjudication but in view of all of the circumstances, he or she is entitled to indemnification of such expenses. Notwithstanding the foregoing, to the extent that any Indemnitee has been successful, on the merits or otherwise, he or she will be indemnified by us against all expenses (including attorneys’ fees) actually and reasonably incurred in connection therewith. Expenses must be advanced to an Indemnitee under certain circumstances.

We have entered into indemnification agreements with each of our directors and officers. These indemnification agreements require us, among other things, to indemnify our directors and officers for

<div align='center'>II-2</div>

TABLE OF CONTENTS

some expenses, including attorneys’ fees, judgments, fines and settlement amounts incurred by a director or officer in any action or proceeding arising out of his or her service as one of our directors or officers, or any of our subsidiaries or any other company or enterprise to which the person provides services at our request. We maintain a general liability insurance policy that covers certain liabilities of directors and officers of our corporation arising out of claims based on acts or omissions in their capacities as directors or officers. Item 16. Exhibits

| ​ 
 ​ 
 ​ 
 ​ | ExhibitNumber 
          1.1* 
           1.2 
           3.1 | ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ | Description                                                                                                                                                                                                            
 Form of Underwriting Agreement.                                                                                                                                                                                        
 Equity Distribution Agreement, dated as of August 13, 2025, by and between Immuneering Corporation and Piper Sandler & Co.                                                                                             
 Amended and Restated Certificate of Incorporation of Immuneering Corporation (incorporated by reference to Exhibit 3.1 of the Company’s Quarterly Report on Form 10-Q filed with the SEC on September 9, 2021).        | ​ 
 ​ 
 ​ 
 ​ |
|:--|--------------:|:--|:--|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:--|
| ​ |           3.2 | ​ | ​ | Amended and Rest